Check here for the latest on COVID-19 diagnosis and treatment
This survey study assesses the acceptability of coronavirus disease 2019 (COVID-19) vaccine mandates among members of the US public.
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
This case report describes a patient with coronavirus disease 2019 who experienced severe ocular neuropathy with panuveitis, resulting in permanent loss of visual acuity.
This cohort study examines rates of SARS-CoV-2 infection among patients with cancer receiving antitumor treatment.
This Viewpoint explores the consequences of COVID-19–related social distancing on health behaviors that may result in better or worse outcomes for individuals with cancer.
This Viewpoint uses CDC data to compare the COVID-19 mortality rate in 2020 with prior leading causes of death (heart disease, cancer, lung disease, and injury) to put into context the cost of the infection in loss of life in the United States.
This cohort study assesses outcomes from early tracheostomy in the airway management of patients with COVID-19 requiring mechanical ventilation.
This study compares all-cause excess mortality and COVID-19–related mortality during the early pandemic period (March-July 2020) with unintentional drug overdoses, the usual leading cause of death in young adults, during the same period in 2018 among adults aged 25 to 44 years.
In this Medical News article, Ala Stanford, MD, founder of Philadelphia’s Black Doctors COVID-19 Consortium, explains how she established COVID-19 testing sites for the city’s Black residents.
This cross-sectional study analyzes trends in suicidality by race/ethnicity during the coronavirus disease 2019 (COVID-19) pandemic.
This study uses commercial and Medicare Advantage claims data to compare medication fills, outpatient visits, and urine tests for opioid use disorder in January-May 2020 vs 2019.
This study examined outpatient buprenorphine dispensing patterns in Texas before vs after the Drug Enforcement Administration temporarily relaxed outpatient buprenorphine prescribing regulations in March 2020 in response to the COVID-19 pandemic.
This Medical News article discusses the top-viewed research articles published across the JAMA Network in the past year.
This JAMA Live Highlights feature provides comments about the coronavirus 2019 pandemic from experts in clinical medicine, public health, and health policy expressed during livestream interviews with JAMA Network Editor in Chief Howard Bauchner, MD.
This Viewpoint discusses individual- and system-level barriers and solutions for people with serious mental illness to access coronavirus disease 2019 vaccination when it is available.
This Viewpoint discusses 4 factors that explain transmission risk during aerosol-generating medical procedures.
This Viewpoint proposes behavioral economic and social marketing strategies to motivate coronavirus disease 2019 (COVID-19) vaccination among the public, including making the vaccine free and accessible, requiring it for access to valued activities or settings, and securing public endorsements from leaders or celebrities to ease perceptions of safety and acceptability.
This Viewpoint proposes that prioritizing all placebo-group participants in coronavirus vaccine trials as vaccine first receivers could perpetuate health inequities and compromise the chance to learn from their participation, proposing instead to limit prioritization to placebo participants who would be prioritized for vaccination anyway under NASEM or ACIP frameworks.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: